Truist Securities Maintains Buy on Compugen, Lowers Price Target to $4
Benzinga Newsdesk 2 years ago
NewsPrice TargetAnalyst Ratings
Truist Securities analyst Asthika Goonewardene maintains Compugen (NASDAQ:CGEN) with a Buy and lowers the price target from $5 to $4.
Truist Securities analyst Asthika Goonewardene maintains Compugen (NASDAQ:CGEN) with a Buy and lowers the price target from $5 to $4.